Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02198079 · ClinicalTrials.gov registry record
A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida
A clinical trial of Cystic Fibrosis and Pediatrics, sponsored by University of Miami.
- Completed
- Registry status
- 85
- Enrollment target
- 1
- Study location
NCT02198079 is a study of Cystic Fibrosis and Pediatrics that has completed, run by University of Miami. The registered enrollment target is 85 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02198079, a study of Cystic Fibrosis and Pediatrics, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the prevalence of nontuberculous mycobacterial infection (NTM) in pediatric patients with cystic fibrosis in the State fo Florida. HYPOTHESIS: There is high prevalence of NTM in CF pediatric population in the State of Florida, and likely higher than in the rest of the country.
Conditions Studied
Interventions
- BIOLOGICAL Sputum
Study Locations (1)
Florida
- University of Miami, Miller School of Medicine - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2010-03 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02198079
The ClinicalTrials.gov registry entry for NCT02198079 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (53% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Sputum is the first listed.
NCT02198079 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02198079 about?
NCT02198079 is a clinical study titled "A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida". To determine the prevalence of nontuberculous mycobacterial infection (NTM) in pediatric patients with cystic fibrosis in the State fo Florida. HYPOTHESIS: There is high prevalence of NTM in CF pediatric population in the State of Florida, and likely higher than in the rest of the country.
What is the current status of trial NCT02198079?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2010-03. Estimated completion is 2015-03.
What conditions does trial NCT02198079 study?
This clinical trial studies the following conditions: Cystic Fibrosis, Pediatrics.
What interventions are being tested in trial NCT02198079?
The interventions under investigation include: Sputum (BIOLOGICAL).
Who is sponsoring clinical trial NCT02198079?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02198079 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RECRUITING · Phase 2
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RECRUITING
-
Assessing Tenapanor as a Treatment of CF-related Constipation.
RECRUITING · Phase 3
-
Genetics of Insulin and Incretins in Cystic Fibrosis
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.